AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Saved in:
| Title: | AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma. |
|---|---|
| Authors: | Strecker, M. I.1,2,3, Wlotzka, K.1,2,3, Strassheimer, F.1,2,3, Roller, B.1,2,3, Ludmirski, G.1,2,3, König, S.1,2,3, Röder, J.3,4, Opitz, C.5, Alekseeva, T.3,4, Reul, J.6, Sevenich, L.2,3,4, Tonn, T.5,7, Wels, W. S.2,3,4, Steinbach, J. P.1,2,3, Buchholz, C. J.3,6,8, Burger, M. C.1,2,3 michael.burger@kgu.de |
| Source: | OncoImmunology. 2022, Vol. 11 Issue 1, p1-19. 19p. |
| Database: | Academic Search Ultimate |
| ISSN: | 21624011 |
|---|---|
| DOI: | 10.1080/2162402X.2022.2127508 |
